Assistant Clinical Professor of Surgery, Massachusetts General Hospital
Urology
Dr. Niall M. Heney, MD
|
|
Give Review
Niall Heney is an expert in the field of Urology. He has 5 awards "America's Top Doctors", "Boston Magazine", "America's Top Doctors for Cancer", "Boston Herald" and "Super Doctor". Niall M. Heney, MD is a published physician as well. He has 75 publications published. The latest was: Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chem... He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Long-Term Outcomes of Organ Preservation in Patients with Small Cell Carcinoma of the Bladder.
- Long-term outcomes in patients with muscle-invasive Bladder cancer after selective Bladder-preserving combined-modality therapy: a pooled analysis of radiation therapy...
- Nomograms Predicting Response to Therapy and Outcomes After Bladder-Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer.
- Trimodality Therapy for Bladder Conservation in Treatment of Invasive Bladder Cancer.
- Immunohistochemistry as an adjunct in the differential diagnosis of radiation-induced atypia versus urothelial carcinoma in situ of the Bladder: a study of 45 cases.
- Complications and Long-Term Results of Salvage Cystectomy After Failed Bladder Sparing Therapy for Muscle Invasive Bladder Cancer.
- Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience.
- Late pelvic toxicity after Bladder-sparing therapy in patients with invasive Bladder cancer: RTOG 89-03, 95-06, 97-06, 99-06.
- Phase I-II RTOG study (99-06) of patients with muscle-invasive Bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy fol...
- Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 39-2003. A 33-year-old woman with gross Hematuria.
- Selective Bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive Bladder cancer.
- Selective Bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retaine...
- The initial results in muscle-invading Bladder cancer of RTOG 95-06: phase I/II trial of transurethral surgery plus radiation therapy with concurrent cisplatin and 5-f...
- An update of combined modality therapy for patients with muscle invading Bladder cancer using selective Bladder preservation or cystectomy.
- Phase III trial of neoadjuvant chemotherapy in patients with invasive Bladder cancer treated with selective Bladder preservation by combined radiation therapy and chem...
- A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluorouracil and twice daily radiation followed by selective Bladder preservation in ...
- An update of selective Bladder preservation by combined modality therapy for invasive Bladder cancer.
- The case for radiotherapy with or without chemotherapy in high-risk superficial and muscle-invading Bladder cancer.
- Invasive Bladder cancer: treatment strategies using transurethral surgery, chemotherapy and radiation therapy with selection for Bladder conservation.
- Treatment strategies using transurethral surgery, chemotherapy, and radiation therapy with selection that safely allows Bladder conservation for invasive Bladder cancer.
- Adjuvant and salvage irradiation following radical prostatectomy for prostate Cancer.
- Combined modality treatment with selective Bladder conservation for invasive Bladder cancer: long-term tolerance in the female patient.
- Bladder preservation by combined modality therapy for invasive Bladder cancer.
- Opportunities with combined modality therapy for selective organ preservation in muscle-invasive Bladder cancer.
- Conservative surgery, patient selection, and chemoradiation as organ-preserving treatment for muscle-invading Bladder cancer.
- Time to second prostate-specific antigen failure is a surrogate endpoint for prostate Cancer death in a prospective trial of therapy for localized disease.
- Radiochemotherapy for invasive carcinoma of the Bladder.
- Selective Bladder preservation by combination treatment of invasive Bladder cancer.
- Preoperative irradiation as an adjuvant in the surgical management of patients with invasive Bladder cancer.
- Erectile impotence as complication of direct vision cold knife urethrotomy.
- Prognostic factors in carcinoma of the ureter.
- The influence of perinephric fat involvement on survival in patients with Renal cell carcinoma extending into the inferior vena cava.
- Ta and T1 Bladder cancer: location, recurrence and progression.
- Transitional cell carcinoma of Renal pelvis.
- Carcinoma in situ of the urinary Bladder with and without associated vesical neoplasms.
- Primary adenocarcinoma of urinary Bladder.
- Superficial Bladder cancer: progression and recurrence.
- Invasive Bladder cancer: tumor configuration, lymphatic invasion and survival.
- UreteroColic fistula.
- Renal scintigraphy in pyelonephritis.
- Treatment of advanced breast carcinoma with drostanolone propionate. A case report.
- Renal hilar lymph. Effects of diuresis on flow and composition in dogs.
- The renal lymphatic system during obstructed Urine flow.
- Full-dose irradiation for patients with invasive Bladder carcinoma: clinical and histological factors prognostic of improved survival.
- Condyloma acuminatum of the Bladder and ureter: case report and review of the literature.
- Ureteroscopy: the initial experience.
- Mitomycin for patients who have failed on thiotepa. The National Bladder Cancer Group.
- First-line chemotherapy of superficial Bladder cancer: mitomycin vs thiotepa.
- Invasive Bladder carcinoma: preliminary report of selective Bladder conservation by transurethral surgery, upfront MCV (methotrexate, cisplatin, and vinblastine) chemo...
- Radiation therapy for localized Prostate carcinoma: experience at the Massachusetts General Hospital (1973-1981).
- Intravesical thiotepa versus mitomycin C in patients with Ta, T1 and TIS transitional cell carcinoma of the Bladder: a phase III prospective randomized study.
- Intravesical chemotherapy: how effective is it?
- The integration of chemotherapy, radiotherapy and transurethral surgery in Bladder-sparing approaches for patients with invasive tumors.
- Can chemo-radiotherapy plus transurethral tumor resection make cystectomy unnecessary for invasive Bladder cancer?
- Preliminary results in invasive Bladder cancer with transurethral resection, neoadjuvant chemotherapy and combined pelvic irradiation plus cisplatin chemotherapy.
- A progress report on the results of multimodality therapy for muscle-invasive Bladder cancer.
- Interval report of a phase I-II study utilizing multiple modalities in the treatment of invasive Bladder cancer. A Bladder-sparing trial.
- Prognostic factors in invasive Bladder carcinoma in a prospective trial of preoperative adjuvant chemotherapy and radiotherapy.
- Biopsy after external beam radiation therapy for adenocarcinoma of the Prostate: correlation with original histological grade and current Prostate specific antigen lev...
- Natural history of superficial Bladder cancer. Prognostic features and long-term disease course.
- Deoxyribonucleic acid flow cytometry in invasive Bladder carcinoma: a possible predictor for successful Bladder preservation following transurethral surgery and chemot...
- Radio-chemotherapy for invasive carcinoma of the Bladder.
- A new technique to aid catheterization of a traumatized urethral Stricture.
- Positive urinary cytology in patients without evident tumor.
- Autosuturing device in intestinal urinary conduits.
- Biopsy of apparently normal urothelium in patients with Bladder carcinoma.
- The effect of intravesical thio-tepa on normal and tumor urothelium.
- Ileal conduit hemorrhage secondary to portal hypertension.
- Selective Bladder preservation for muscle-invasive transitional cell carcinoma of the urinary Bladder.
- Bladder preservation: optimizing radiotherapy and integrated treatment strategies.
- Bladder-sparing approaches to invasive disease.
- Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with mu...
- Surgery: selective Bladder-preserving therapy for muscle-invasive cancer.
- The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive Bladder cancer: is immediate cystecto...
Schools
University of Dublin Trinity College School of Physic
Sir Patrick Duns Hospital
Massachusetts General Hospital
Reg Hospital
Procedures Preformed
- Cystectomy
- Cystotomy
- Cystourethroscopy and Transurethral Resection of Bladder Neck
- Kidney and Ureter Removal
- View All
Conditions Treated
- Balanoposthitis
- Bedwetting
- Bladder Atony
- Bladder Cancer
- View All
Doctors Specialties
- Urology
Accepted Insurances
Awards
- America's Top Doctors
- Boston Magazine
- America's Top Doctors for Cancer
- Boston Herald
- Super Doctor
Education
-
Massachusetts General Hospital -
University of Dublin Trinity College
Hospital
-
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1134195639 | |
| NPPES Provider LastName | HENEY | |
| NPPES Provider FirstName | NIALL | |
| NPPES Provider ZIPCode | 02114 | |
| NPPES Provider State | MA | |
| Specialty Description | Urology | |
| Total Claim Count | 551.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1134195639 |
| Last Name Of The Provider | HENEY |
| First Name Of The Provider | NIALL |
| View All |
Similar Doctors
|
|
Dr. Theodore J. Ongaro, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Abhishek Seth, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sameer M. Deshmukh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Simpa S. Salami, MD |
|
|
Dr. Michael P. O'Leary, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Solomon Berg, MD |
|
|
Dr. W S. McDougal, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Tony Luongo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrey Layer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph D. Shirk, MD |